Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

Scientists found that horses bypass a genetic 'stop sign' that other species have during intense exercise, allowing them to ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Genome wide association studies (GWAS) have identified hundreds of genome regions containing thousands of genetic variants ...

School of Medicine have developed a new tool that could help reveal the genetic causes of cancer, predict patient outcome and ...

Could it be that one of only three known markers directly targeting the DNA does not exist outside the realm of microbes? Now ...

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing ...

Florida, the FBI and federal agencies are involved in a permit probe in Collier County involving the fraudulent use of a retired architect's seal.

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper ...